Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
107: Legal dos and don’ts of EIS and VCTs | Tom Wilde of Shoosmiths
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Allergy Therapeutics plc
Life Sciences
Continuing to gain market share
By
Dr Martin Hall
10 Oct 2017
City of London Investment Group
Financials
Q1 showing steady growth
By
Dr Brian Moretta
10 Oct 2017
ValiRx
Life Sciences
Progressing all the pipeline
06 Oct 2017
Scancell Holdings
Life Sciences
Preparing for next clinical studies
By
Dr Martin Hall
03 Oct 2017
Advanced Oncotherapy
Life Sciences
Technology advances & stronger balance sheet
By
Dr Martin Hall
02 Oct 2017
ValiRx
Life Sciences
Positive early data from VAL401
28 Sep 2017
R.E.A. Holdings
Agriculture
1H 2017: Bouncing Back
By
Yingheng Chen
26 Sep 2017
Gateley Plc
Services
FY 17 results and initiation
By
Steve Clapham
21 Sep 2017
Collagen Solutions Plc
Life Sciences
Engineering towards CE Mark
By
Dr Martin Hall
21 Sep 2017
City of London Investment Group
Financials
Entering a new phase
By
Dr Brian Moretta
18 Sep 2017
Collagen Solutions Plc
Life Sciences
Delivering biomaterials for revenue growth
By
Dr Martin Hall
15 Sep 2017
Prev
1
...
77
78
79
80
81
...
84
Next
